AI Terminal
DIRECTA PLUS PLC
Share Issue/Capital Change • Dec 9, 2021
7601_rns_2021-12-09_6cb35495-2e71-4328-81b9-69aa2decaafa.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2001V
Directa Plus PLC
09 December 2021
9 December 2021
Directa Plus plc
Close of Bookbuild and Subscription
Further to the announcement made at 12.30 p.m. today, the Placing and the Subscription have now closed and the Bookbuild has been successfully concluded.
Participants in the Placing will be contacted by the Joint Brokers as soon as practicable to confirm their allocations. A further announcement will be made in due course confirming details of the Fundraise.
Capitalised terms used in this announcement shall, unless the context provides otherwise, bear the same meaning ascribed to such terms in the announcement made by the Company at 12.30 p.m. today to announce the launch of the Fundraise.
For further information, please contact:
| Directa Plus plc | +39 02 36714458 |
| Giulio Cesareo, CEO | |
| Giorgio Bonfanti, CFO | |
| Cenkos Securities plc (Nominated Adviser and Joint Broker) | +44 131 220 6939 |
| Neil McDonald | |
| Adam Rae | |
| Singer Capital Markets Securities Limited (Joint Broker) | +44 20 7496 3069 |
| Rick Thompson | |
| Phil Davies | |
| Tavistock (Financial PR and IR) | +44 20 7920 3150 |
| Simon Hudson | |
| Heather Armstrong |
The person responsible for arranging the release of this Announcement on behalf of the Company is Giorgio Bonfanti, Chief Financial Officer of the Company.
Notes to Editors
Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.
This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+) have multiple applications due to its properties. These G+ products can be categorised into various families, with different products being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEUKUWRABUURAA